Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis

Y Lacasse, R Casaburi, P Sliwinski… - The Lancet …, 2022 - thelancet.com
Background Long-term oxygen therapy (LTOT) improves survival in patients with chronic
obstructive pulmonary disease (COPD) and severe hypoxaemia. However, the best method …
被引用次数：33 相关文章

Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis

Y Lacasse, R Casaburi, P Sliwinski, A Chaouat… - The Lancet Respiratory …, 2022 - Elsevier
Background Long-term oxygen therapy (LTOT) improves survival in patients with chronic
obstructive pulmonary disease (COPD) and severe hypoxaemia. However, the best method …

Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis

Y Lacasse, R Casaburi, P Sliwinski… - The Lancet …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Long-term oxygen therapy (LTOT) improves survival in patients with chronic
obstructive pulmonary disease (COPD) and severe hypoxaemia. However, the best method …

Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis

Y Lacasse, R Casaburi, P Sliwinski, A Chaouat… - The Lancet Respiratory …, 2022 - Elsevier
Background Long-term oxygen therapy (LTOT) improves survival in patients with chronic
obstructive pulmonary disease (COPD) and severe hypoxaemia. However, the best method …